Page last updated: 2024-11-05

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Lower Urinary Tract Symptom

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole has been researched along with Lower Urinary Tract Symptom in 1 studies

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole: antineoplastic; activates platelet guanylate cyclase; a radiosensitizing agent and guanylate cyclase activator; structure in first source
lificiguat : A member of the class of indazoles that is 1H-indazole which is substituted by a benzyl group at position 1 and a 5-(hydroxymethyl)-2-furyl group at position 3. It is an activator of soluble guanylate cyclase and inhibits platelet aggregation.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mónica, FZ1
Antunes, E1

Reviews

1 review available for 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Lower Urinary Tract Symptom

ArticleYear
Stimulators and activators of soluble guanylate cyclase for urogenital disorders.
    Nature reviews. Urology, 2018, Volume: 15, Issue:1

    Topics: Aging; Animals; Benzoates; Diabetes Complications; Enzyme Activators; Humans; Hypertension; Indazole

2018